
    
      It is very common that Chinese Medicine Injection used in hospitals in mainland China.
      However safety problems rose in recent years. There could be many uncertain factors influence
      Chinese Medicine Injection in clinical practice.

      In order to ensure the safety of public drug use and lower drug-induced risks, a registry
      study for Reduning injection safety surveillance with 3000 patients will be conducted from
      Jan.2013 to Mar.2013.At the same time,Patients who have anaphylactic reaction are selected as
      the allergic group and not have anaphylactic reaction are selected as the control group.The
      proportion of allergic group and control group is 1:4.All the patients who are selected
      should draw blood.

      Eligibility criteria Patients who will use Reduning injection in selected hospitals.
    
  